These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 25504449

  • 1. Individualized texting for adherence building (iTAB): improving antiretroviral dose timing among HIV-infected persons with co-occurring bipolar disorder.
    Moore DJ, Poquette A, Casaletto KB, Gouaux B, Montoya JL, Posada C, Rooney AS, Badiee J, Deutsch R, Letendre SL, Depp CA, Grant I, Atkinson JH, HIV Neurobehavioral Research Program (HNRP) Group.
    AIDS Behav; 2015 Mar; 19(3):459-71. PubMed ID: 25504449
    [Abstract] [Full Text] [Related]

  • 2. Individualized texting for adherence building (iTAB) for methamphetamine users living with HIV: A pilot randomized clinical trial.
    Moore DJ, Pasipanodya EC, Umlauf A, Rooney AS, Gouaux B, Depp CA, Atkinson JH, Montoya JL.
    Drug Alcohol Depend; 2018 Aug 01; 189():154-160. PubMed ID: 29958127
    [Abstract] [Full Text] [Related]

  • 3. Outcomes of Psychoeducation and a Text Messaging Adherence Intervention Among Individuals With Hypertension and Bipolar Disorder.
    Levin JB, Sajatovic M, Rahman M, Aebi ME, Tatsuoka C, Depp C, Cushman C, Johnston E, Cassidy KA, Blixen C, Eskew L, Klein PJ, Fuentes-Casiano E, Moore DJ.
    Psychiatr Serv; 2019 Jul 01; 70(7):608-612. PubMed ID: 30991908
    [Abstract] [Full Text] [Related]

  • 4. Using mHealth to improve adherence and reduce blood pressure in individuals with hypertension and bipolar disorder (iTAB-CV): study protocol for a 2-stage randomized clinical trial.
    Levin JB, Moore DJ, Depp C, Montoya JL, Briggs F, Rahman M, Stange KC, Einstadter D, Weise C, Conroy C, Yala J, Radatz E, Sajatovic M.
    Trials; 2022 Jun 29; 23(1):539. PubMed ID: 35768875
    [Abstract] [Full Text] [Related]

  • 5. Randomized Trial of Individualized Texting for Adherence Building (iTAB) Plus Motivational Interviewing for PrEP Adherence in Transgender Individuals: The iM-PrEPT Study.
    Morris SR, Jain S, Blumenthal J, Bolan R, Dubé MP, Henderson P, Corado K, Sun S, He F, Chow K, Burke L, Anderson PL, Moore DJ.
    J Acquir Immune Defic Syndr; 2022 Dec 15; 91(5):453-459. PubMed ID: 36084200
    [Abstract] [Full Text] [Related]

  • 6. A Culturally Adapted SMS Text Messaging Intervention to Promote Antiretroviral Therapy Adherence Among African Americans: Protocol for a Single-Arm Trial.
    Kohli M, Pasipanodya EC, Montoya JL, Marquine M, Hoenigl M, Serrano V, Cushman C, Garcia R, Kua J, Gant V, Rojas S, Moore DJ.
    JMIR Res Protoc; 2020 Dec 10; 9(12):e21592. PubMed ID: 33300885
    [Abstract] [Full Text] [Related]

  • 7. Preliminary Evidence for Feasibility, Use, and Acceptability of Individualized Texting for Adherence Building for Antiretroviral Adherence and Substance Use Assessment among HIV-Infected Methamphetamine Users.
    Moore DJ, Montoya JL, Blackstone K, Rooney A, Gouaux B, Georges S, Depp CA, Atkinson JH, Tmarc Group T.
    AIDS Res Treat; 2013 Dec 10; 2013():585143. PubMed ID: 24078868
    [Abstract] [Full Text] [Related]

  • 8. Randomized Controlled Trial of Daily Text Messages to Support Adherence to Preexposure Prophylaxis in Individuals at Risk for Human Immunodeficiency Virus: The TAPIR Study.
    Moore DJ, Jain S, Dubé MP, Daar ES, Sun X, Young J, Corado K, Ellorin E, Milam J, Collins D, Blumenthal J, Best BM, Anderson P, Haubrich R, Morris SR.
    Clin Infect Dis; 2018 May 02; 66(10):1566-1572. PubMed ID: 29228144
    [Abstract] [Full Text] [Related]

  • 9. Feasibility of interactive text message response (ITR) as a novel, real-time measure of adherence to antiretroviral therapy for HIV+ youth.
    Dowshen N, Kuhns LM, Gray C, Lee S, Garofalo R.
    AIDS Behav; 2013 Jul 02; 17(6):2237-43. PubMed ID: 23546844
    [Abstract] [Full Text] [Related]

  • 10. Pilot RCT of bidirectional text messaging for ART adherence among nonurban substance users with HIV.
    Ingersoll KS, Dillingham RA, Hettema JE, Conaway M, Freeman J, Reynolds G, Hosseinbor S.
    Health Psychol; 2015 Dec 02; 34S(0):1305-15. PubMed ID: 26651472
    [Abstract] [Full Text] [Related]

  • 11. Development of a personalized bidirectional text messaging tool for HIV adherence assessment and intervention among substance abusers.
    Ingersoll K, Dillingham R, Reynolds G, Hettema J, Freeman J, Hosseinbor S, Winstead-Derlega C.
    J Subst Abuse Treat; 2014 Jan 02; 46(1):66-73. PubMed ID: 24029625
    [Abstract] [Full Text] [Related]

  • 12. HIV-infected individuals with co-occurring bipolar disorder evidence poor antiretroviral and psychiatric medication adherence.
    Moore DJ, Posada C, Parikh M, Arce M, Vaida F, Riggs PK, Gouaux B, Ellis RJ, Letendre SL, Grant I, Atkinson JH, HIV Neurobahavioral Research Program (HNRP).
    AIDS Behav; 2012 Nov 02; 16(8):2257-66. PubMed ID: 22041931
    [Abstract] [Full Text] [Related]

  • 13. Results of a randomized controlled trial to assess the effects of a mobile SMS-based intervention on treatment adherence in HIV/AIDS-infected Brazilian women and impressions and satisfaction with respect to incoming messages.
    da Costa TM, Barbosa BJ, Gomes e Costa DA, Sigulem D, de Fátima Marin H, Filho AC, Pisa IT.
    Int J Med Inform; 2012 Apr 02; 81(4):257-69. PubMed ID: 22296762
    [Abstract] [Full Text] [Related]

  • 14. Mobile Text Messaging to Improve Medication Adherence and Viral Load in a Vulnerable Canadian Population Living With Human Immunodeficiency Virus: A Repeated Measures Study.
    King E, Kinvig K, Steif J, Qiu AQ, Maan EJ, Albert AY, Pick N, Alimenti A, Kestler MH, Money DM, Lester RT, Murray MCM.
    J Med Internet Res; 2017 Jun 01; 19(6):e190. PubMed ID: 28572079
    [Abstract] [Full Text] [Related]

  • 15. Approaches to identifying appropriate medication adherence assessments for HIV infected individuals with comorbid bipolar disorder.
    Badiee J, Riggs PK, Rooney AS, Vaida F, Grant I, Atkinson JH, Moore DJ, Hiv Neurobehavioral Research Program (HNRP) Group.
    AIDS Patient Care STDS; 2012 Jul 01; 26(7):388-94. PubMed ID: 22686169
    [Abstract] [Full Text] [Related]

  • 16. Feasibility and acceptability of novel methods to estimate antiretroviral adherence: A longitudinal study.
    Saberi P, Ming K, Legnitto D, Neilands TB, Gandhi M, Johnson MO.
    PLoS One; 2019 Jul 01; 14(1):e0210791. PubMed ID: 30645641
    [Abstract] [Full Text] [Related]

  • 17. A Randomized Controlled Trial of Personalized Text Message Reminders to Promote Medication Adherence Among HIV-Positive Adolescents and Young Adults.
    Garofalo R, Kuhns LM, Hotton A, Johnson A, Muldoon A, Rice D.
    AIDS Behav; 2016 May 01; 20(5):1049-59. PubMed ID: 26362167
    [Abstract] [Full Text] [Related]

  • 18. Pilot feasibility study of Heart2HAART: a smartphone application to assist with adherence among substance users living with HIV.
    Himelhoch S, Kreyenbuhl J, Palmer-Bacon J, Chu M, Brown C, Potts W.
    AIDS Care; 2017 Jul 01; 29(7):898-904. PubMed ID: 28043176
    [Abstract] [Full Text] [Related]

  • 19. INcentives and ReMINDers to Improve Long-Term Medication Adherence (INMIND): impact of a pilot randomized controlled trial in a large HIV clinic in Uganda.
    Linnemayr S, Odiit M, Mukasa B, Ghai I, Stecher C.
    J Int AIDS Soc; 2024 Jun 01; 27(6):e26306. PubMed ID: 38923298
    [Abstract] [Full Text] [Related]

  • 20. Differential Medication Attitudes to Antihypertensive and Mood Stabilizing Agents in response to an Automated Text-Messaging Adherence Enhancement Intervention.
    Klein P, Aebi ME, Sajatovic M, Depp C, Moore D, Blixen C, Levin JB.
    J Behav Cogn Ther; 2020 Apr 01; 30(1):57-64. PubMed ID: 33409504
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.